Company Monitoring Page for Vertex

latest headlines for company on cafepharma

Interview: Vertex CEO concerned about investors' 'hyper-focus' on hep C
Fierce Biotech
Wed, 12/21/11 - 01:15 pm
Tags:
hepatitis C, Vertex, Pharma CEOs, Matt Emmens
10 Biotech Stock Predictions for 2012
TheStreet.com
Tue, 12/20/11 - 11:13 am
Tags:
Amgen, FDA, Oncothyreon, Merck KGaA, Vical, GSK, Seattle Genetics, M&A, Celgene, Biomarin, Amag Pharmaceuticals, Momenta, ONYX Pharmaceuticals, Cell Therapeutics, Roche, Aeterna Zentaris, Arena Pharmaceuticals, Vertex, Spectrum Pharmaceuticals
Vertex Names Jeff Leiden as New CEO, Staring Down Tough New Competition
Xconomy
Thu, 12/15/11 - 11:31 am
Tags:
Jeff Leiden, Vertex, Pharma CEOs
FDA Grants Priority Review for KALYDECO™ (ivacaftor), the First Potential Medicine to Target the Underlying Cause of Cystic Fibrosis
Yahoo
Thu, 12/15/11 - 11:02 am
Tags:
FDA, Kalydeco, Vertex, VX-770, cystic fibrosis
Health Care's 5 Worst November Flops
Motley Fool
Thu, 12/1/11 - 11:42 am
Tags:
Vertex, Seattle Genetics, Human Genome Sciences, Mako Surgical, Dendreon
22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com
Tue, 11/29/11 - 09:09 am
Tags:
Amarin, AMR101, Ironwood, linaclotide, Merck, Ariad, ridaforolimus, Vivus, Qnexa, Avanafil, Amgen, Xgeva, Cell Therapeutics, pixantrone, Kalydeco, Vertex, ONYX Pharmaceuticals, Carfilzomib, Pfizer, Bristol-Myers Squibb, Eliquis, Chelsea Therapeutics, Northera, Levadex, MAP Pharmaceuticals, Roche, Curis, vismodegib, Biogen Idec, Elan, Tysabri, Amylin, Bydureon, Dapagliflozin, Uplypso, Protalix BioTherapeutics, Teva Pharmaceuticals, BioSante, Bio-T-Gel, Corlux, Corcept Therapeutics, Discovery Labs, Surfaxin
Gilead's Pharmasset Purchase Could Help Double Market Cap By 2020
Seeking Alpha
Mon, 11/28/11 - 11:38 am
Tags:
Gilead, Pharmasset, M&A, hepatitis C, GSK, JNJ, Bristol-Myers Squibb, PSI-7977, Vertex, HIV
Vertex: competition fears hit hard
FT.com
Mon, 11/28/11 - 09:53 am
Tags:
Incivek, Merck, JNJ, Vertex
HOLX appoints Vertex's Stamoulis to board | Personnel Moves
Mass Device
Fri, 11/4/11 - 10:50 pm
Tags:
HOLX, Vertex, Management
5 One-Drug Wonders Going for No. 2
Motley Fool
Tue, 11/1/11 - 11:09 am
Tags:
Dendreon, Provenge, DN24-02, Elan, Tysabri, bapineuzumab, ONYX Pharmaceuticals, Bayer, regorafenib, Carfilzomib, Nexavar, Vertex, Merck, Incivek, Kalydeco, Momenta, Lovenox, Copaxone, Teva Pharmaceuticals
Pharmasset Takes Lead in Race to Develop Hep C Therapy By Pill
TheStreet.com
Tue, 11/1/11 - 09:01 am
Tags:
Pharmasset, hepatitis C, Ribavirin, Vertex, Abbott Laboratories, PSI-7977, JNJ, Roche, Bristol-Myers Squibb
Merck's Penance Has Gone On Long Enough
Investopedia
Tue, 11/1/11 - 08:55 am
Tags:
Merck, Alexion, Forest Labs, JNJ, Gilead, Eli Lilly, Novartis, Pfizer, Vertex
November Catalysts for Biotech and Drug Stocks
Minyanville
Mon, 10/31/11 - 11:34 am
Tags:
FDA, Regeneron, Vertex, Pharmasset, pSivida, Alimera, Salix, Teva Pharmaceuticals, BioSante, Transcept
Vertex Bests Merck in New Hepatitis C Drug Sales
NY Times, NY
Sat, 10/29/11 - 12:55 pm
Tags:
hepatitis C, Merck, Vertex, Incivek, Victrelis
Vertex A Steal Based On Blockbuster Hepatitis C Drug Sales
Seeking Alpha
Fri, 10/28/11 - 09:34 am
Tags:
Vertex, earnings, hepatitis C, Bristol-Myers Squibb, JNJ, Eli Lilly, Merck, SciClone, Pharmasset
Vertex tests shorter Incivek therapy in patient subset
Fierce Pharma
Mon, 10/24/11 - 12:02 pm
Tags:
Vertex, Incivek, hepatitis C
Vertex CEO sees "historic launch" for Hep-C drug
Reuters
Thu, 10/20/11 - 12:51 pm
Tags:
hepatitis C, Vertex, Pharma CEOs, Incivek, Matthew Emmens
Vertex Seeks FDA Green Light for Cystic Fibrosis Drug, Second Potential Hit of Big Year
Xconomy
Wed, 10/19/11 - 10:39 am
Tags:
Vertex, FDA, cystic fibrosis, ivacaftor, Kalydeco, VX-770
Vertex Declines After Sales of Incivek Are Little Changed
Bloomberg
Mon, 10/17/11 - 12:04 pm
Tags:
Vertex, Incivek, hepatitis C
Top Mid- And Large-Cap Biotech Picks By Legendary Fund Managers
Seeking Alpha
Fri, 10/14/11 - 11:41 am
Tags:
Alexion, Amgen, Amylin, Biogen Idec, Biomarin, Celgene, Gilead, Human Genome Sciences, Incyte, ONYX Pharmaceuticals, Seattle Genetics, Vertex, Theravance

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.